Btai investor deadline: bioxcel therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit

San diego , july 15, 2023 /prnewswire/ -- robbins geller rudman & dowd llp announces that purchasers or acquirers of bioxcel therapeutics, inc. (nasdaq: btai) securities between december 15, 2021 and june 28, 2023, both dates inclusive (the "class period") have until september 5, 2023 to seek appointment as lead plaintiff of the bioxcel class action lawsuit. captioned martin v.
BTAI Ratings Summary
BTAI Quant Ranking